2Manavathu EK, Cutright J, Chandrasekar PH. Comparative study of susceptibilities of germinated and ungerminated conidia of Aspergillus fumigatus to various antifungal agents. J Clin Microbiol 1999;40:858 - 861.
3Pujol I, Fernandez- Ballart J, Guarro J. Effect of inoculum form on in vitro antifungal susceptibilities of Aspergillus. spp. J Antimicrob Chemother 2001 ;47:715 - 718.
4Guarro J, Llop C, Aguilar C, et al. Comparison of in vitro antifungal susceptibilities of conidia and hyphae of filamentous fungi. Antimicrob Agents Chemother 1997;41:2760 - 2762.
5Johnson EM, Szekely A, Warnock DW. In vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi. J Antimicrob Chemother 1998;42:741 - 745.
6Meletiadis J, Meis JFGM, Mouton JW, et al. The EUROFUNG Network. In vitro activities of new and conventional antifungal agents againse clinical Scedosporium isolates. Antimicrob Agents Chemother 2002;46:62-68.
7Nakai T, Uno J, Otomo K, et al. In vitro activity of FK463, a novel lipopeptide antifungal agent, against a variety of clinically important molds. Chemotherapy 2002;48: 78 - 81.
8Manavathu EK, Alangaden GJ, Lerner SA. A comparative study of the broth microand macro- dilution techniques for the determination of the in vitro susceptibility of Aspergillus fumigatus. Can J Microbiol 1996;42:960 - 964.
9Kay Mursch,Svorad Trnovec,Heinrich Ratz,Detlef Hammer,Regine Horré,Albrecht Klinghammer,Sybren Hoog,Julianne Behnke-Mursch. Successful treatment of multiple Pseudallescheria boydii brain abscesses and ventriculitis/ependymitis in a 2-year-old child after a near-drowning episode[J] 2006,Child’s Nervous System(2):189～192
10Z. A. Kanafani,Y. Comair,S. S. Kanj. Pseudallescheria boydii cranial osteomyelitis and subdural empyema successfully treated with voriconazole: a case report and literature review[J] 2004,European Journal of Clinical Microbiology & Infectious Diseases(11):836～840
